Login
Home / 4503.T : JPX
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Astellas Pharma Inc.

¥2315 +$185.00 (+8.69%)
JPX · 15 Sep 2026 06:30 UTC
Previous Close
¥2292.5
Day Range
¥2290¥2332
Year Range
¥1557.5¥2717
Market Cap
4.15T
AVG Volume
6.45M
Trailing/Forward PE
11.36/11.61
PEG ratio
11.74
Dividend Yield
3.37%
Next Earnings Date
2026-11-04
Primary Exchange
Tokyo Stock ExchangeJP
Revenue (JPY)
0200B400B600B800B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Net Income (JPY)
-100B0100B200B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Operating Income (JPY)
-200B-100B0100B200B300B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EBITDA (JPY)
0100B200B300B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash Flows (JPY)
0100B200B300B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
EPS (JPY)
-100-5005010024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Expenses (JPY)
-100B0100B200B300B400BR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Cash & Debt (JPY)
0250B500B750B1TCashLong Term DebtShort Term Debt24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Debt ratios
012324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Margins
0%25%50%75%100%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Return on Capital
-10%-5%0%5%10%24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Shares Outstanding
0500M1B1.5B2B24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Dividends (JPY)
010203040Sep 22Mar 23Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Sep 26Mar 27
Book Value Per Share (JPY)
05001000150024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
Total Assets (JPY)
01T2T3T4T24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
PE Ratio
050100150200med 46.21Sep 24Jan 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
2.5%5%7.5%10%12.5%15%med 6.16%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
11.522.5med 1.66Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
68101214med 8.04Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
5101520med 12.68Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
1.522.53med 1.97Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Astellas Pharma Inc.
4503.T
Stockpicker

Video analysis: 4503.T

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.